4-(3-chloro-4-methoxybenzylamino)-2-(4-hydroxypiperidin-1-yl)-N-(pyridin-2-ylmethyl)pyrimidine-5-carboxamide

ID: ALA3354276

PubChem CID: 118720069

Max Phase: Preclinical

Molecular Formula: C24H27ClN6O3

Molecular Weight: 482.97

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(CNc2nc(N3CCC(O)CC3)ncc2C(=O)NCc2ccccn2)cc1Cl

Standard InChI:  InChI=1S/C24H27ClN6O3/c1-34-21-6-5-16(12-20(21)25)13-27-22-19(23(33)28-14-17-4-2-3-9-26-17)15-29-24(30-22)31-10-7-18(32)8-11-31/h2-6,9,12,15,18,32H,7-8,10-11,13-14H2,1H3,(H,28,33)(H,27,29,30)

Standard InChI Key:  TVORLUPCRVONIB-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
    1.4519  -11.6570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4485  -12.4804    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1628  -12.8917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8777  -12.4781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8736  -11.6488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1589  -11.2413    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5861  -11.2327    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5819  -10.4077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2942   -9.9915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5934  -12.8885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5957  -13.7135    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3066  -12.4739    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0057  -10.4035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7177   -9.9881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7139   -9.1622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9923   -8.7536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2834   -9.1713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4257   -8.7451    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.1428   -9.1531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4340  -10.3974    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.3114  -14.1239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3138  -14.9489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6000  -15.3592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6020  -16.1834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3183  -16.5947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0339  -16.1756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0284  -15.3527    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7366  -11.2459    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7405  -10.4244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0294  -10.0134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6882  -10.4238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6879  -11.2497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0287  -11.6654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4078  -10.0100    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  4 10  1  0
 10 11  1  0
 10 12  2  0
  9 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17  9  1  0
 15 18  1  0
 18 19  1  0
 14 20  1  0
 11 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
  1 28  1  0
 28 29  1  0
 28 33  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 31 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3354276

    ---

Associated Targets(Human)

PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PDE5A Phosphodiesterase 5A (190 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 482.97Molecular Weight (Monoisotopic): 482.1833AlogP: 3.04#Rotatable Bonds: 8
Polar Surface Area: 112.50Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.85CX Basic pKa: 5.62CX LogP: 2.71CX LogD: 2.70
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.45Np Likeness Score: -1.65

References

1. Sakamoto T, Koga Y, Hikota M, Matsuki K, Murakami M, Kikkawa K, Fujishige K, Kotera J, Omori K, Morimoto H, Yamada K..  (2014)  The discovery of avanafil for the treatment of erectile dysfunction: a novel pyrimidine-5-carboxamide derivative as a potent and highly selective phosphodiesterase 5 inhibitor.,  24  (23): [PMID:25455484] [10.1016/j.bmcl.2014.10.008]
2. Shaaban MA,Elshaier YAMM,Hammad AH,Farag NA,Hassan Haredy H,AbdEl-Ghany AA,Mohamed KO.  (2020)  Design and synthesis of pyrazolo[3,4-d]pyrimidinone derivatives: Discovery of selective phosphodiesterase-5 inhibitors.,  30  (16): [PMID:32631538] [10.1016/j.bmcl.2020.127337]

Source